RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • FDA approves Amgen heart failure drug Corlanor

    FDA approves Amgen heart failure drug Corlanor
    Biotech company Amgen Inc. took a key step in its expansion into cardiovascular drugs Wednesday when the Food and Drug Administration approved its heart failure drug for sale in the United States. The drug called ivabradine is an oral medication that...
  • U.S. prescription drug spending jumps to record $374 billion

    U.S. prescription drug spending jumps to record $374 billion
    U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act. Spending rose 13 percent, the...
  • Dying can be a pain, but it doesn't have to be

    Dying can be a pain, but it doesn't have to be
    Some 35 years ago my grandfather died a painful death as prostate cancer ravaged his body. His passing did not have to be so excruciating given that hospital staff could have eased his suffering with pain medication. But when my mother asked about the...
  • UnitedHealth to acquire pharmacy benefits firm Catamaran in $12-billion deal

     UnitedHealth to acquire pharmacy benefits firm Catamaran in $12-billion deal
    UnitedHealth Group Inc., the largest health insurer in the United States, agreed to spend more than $12 billion to buy an Illinois pharmacy benefits management firm, saying it is seeking to control the rising costs of prescription drugs. UnitedHealth...
  • UnitedHealth Bulks Up For Prescription Drug Cost Battle

    The nation's largest health insurer, UnitedHealth, will muscle up for its fight against rising prescription drug costs by spending more than $12 billion to buy pharmacy benefits manager Catamaran Corp. Pharmacy benefits managers, or PBMs, help...
  • GNC allowed to sell herbal brand under deal with N.Y. attorney general

    GNC allowed to sell herbal brand under deal with N.Y. attorney general
    Nutritional supplement retailer GNC Holdings Inc. is cleared to sell some of its most popular products, including echinacea, ginseng and St. John’s Wort, under an agreement announced Monday with New York’s attorney general. State...
  • Step therapy encourages sticking to Rx: My Word

    A subject that is receiving attention from Florida legislators this session relates to the use of pharmaceuticals and how those prescription drugs are provided to patients. A topic of particular interest is step therapy, where patients are prescribed...
  • Horizon Pharma buying Hyperion for about $1.1 billion

    Irish firm Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders. Dublin-based Horizon Pharma said Monday that it would pay $46 a share for the Brisbane, Calif., company, marking a 5.6%...
  • Antidepressants: a deadly treatment?

    Antidepressants: a deadly treatment?
    The crash of Germanwings Flight 9525, allegedly the intentional act of co-pilot Andreas Lubitz, and the deaths of all 150 people on board is indeed a tragedy. But some good may come out of it if it induces people to take another look at those substances...
  • Actavis: No apologies for seeking Alzheimer's drug profits

    A lawyer for the Irish manufacturer of an Alzheimer's drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits. Attorney Lisa Blatt told...
  • Mylan offers about $29B for rival generic drugmaker Perrigo

    In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion. Shares of both companies climbed to all-time highs on the news. If they combine, Mylan...